Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin receptors, also known as 5-HT receptors, are a family of G protein-coupled receptors and ligand-gated ion channels that mediate the diverse effects of the neurotransmitter serotonin. They are widely distributed throughout the central and peripheral nervous systems and regulate a vast array of physiological and behavioral processes, making them important therapeutic targets for a variety of disorders.
Agonism, antagonism, or partial agonism at serotonin receptor subtypes, leading to modulation of downstream signaling pathways. For 5-HT3 receptors, drugs can act as channel blockers, preventing cation influx.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin receptor (5-HT receptor).